Ikena is a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. 

Biotechnology

Ikena Oncology

Ikena Oncology's headquarters in Boston, MA, United States

Mark Manfredi

Jotin Marango

Jeffrey Ecsedy

Josep Tabernero

Iain D. Dukes

David Bonita

George D. Demetri

Kevan M. Shokat

Jean-François Formela

Otello Stampacchia

Ron Renaud

Richard Wooster

Neal Rosen

Owen Hughes

Maria Koehler

The Leadership Team at Ikena Oncology is responsible for setting the strategic vision and direction of the company, overseeing the development of novel cancer therapies, and ensuring operational excellence across clinical and financial functions. This team collaborates closely to drive innovation, manage resources, and uphold quality standards in pursuit of advancing targeted oncology treatments.

Leadership Team

The Clinical Development Team at Ikena Oncology is responsible for designing, executing, and overseeing clinical trials to evaluate the efficacy and safety of novel cancer therapies. This team works collaboratively to manage clinical data, ensure regulatory compliance, and guide the clinical strategy to advance promising treatments through the development pipeline.

Clinical Development Team

The Science and Research team at Ikena Oncology is dedicated to discovering and advancing novel cancer therapies. Comprising senior scientists and directors in biomolecular sciences and translational research, the team focuses on understanding and targeting key signaling pathways that contribute to cancer progression, thus driving the development of innovative treatment solutions.

Science and Research

Ikena Oncology

Org chart

Board & advisors

Teams

Leadership Team

Clinical Development Team

Science and Research

Offices

Ikena Oncology

Org chart

Board & advisors

Teams

Leadership Team

Clinical Development Team

Science and Research

Offices

Related companies